On April 24, 2025, at the headquarters of Nam Ha Pharmaceutical Joint Stock Company (Nam Ha Pharma), the signing ceremony of a Memorandum of Understanding on a comprehensive strategic partnership officially took place with Yangtze River Pharmaceutical Group – the largest and most prestigious pharmaceutical corporation in China.

The event marks a new milestone following Nam Ha Pharma’s business trip to Yangtze River in March 2025, with the goal of expanding strategic cooperation, enhancing production capabilities, and improving quality control according to international standards.

China’s No.1 Pharmaceutical Group
Yangtze River is a leading pharmaceutical conglomerate in China, with over 53 years of sustainable development, a workforce of 18,000 employees, 4 R&D centers, and 13 modern manufacturing plants across key cities.

The Group operates under a fully integrated model: research – production – business – science and technology – commerce.

For many consecutive years, Yangtze River has maintained the No.1 position in the Top 100 Pharmaceutical Companies in China, with annual revenue exceeding 10 billion USD.

It has been awarded prestigious international certifications such as cGMP (FDA – USA), EU GMP (Europe), TGA GMP (Australia), PIC/S GMP, and notably the EFQM Global Award – a testament to excellence in governance and sustainable development.

Nam Ha Pharma – Exclusive Strategic Partner in Vietnam
Speaking at the signing ceremony, Mr. Dam Quang Trieu – Vice Chairman of the Board of Directors and General Director of Yangtze River Pharmaceutical Group – emphasized:

“Among many Vietnamese pharmaceutical companies, Nam Ha Pharma is the one and only enterprise chosen as our comprehensive strategic partner.”

This partnership is grounded in shared development principles: integrity as the foundation, quality as the highest goal, and a vision towards sustainable growth and global integration.

Nam Ha Pharma’s products are strictly controlled throughout the entire process – from raw material input, production, testing to post-sales – in order to fulfill its mission:
“Delivering health – Shaping the future.”

Comprehensive cooperation orientation – Reaching out globally
During the working session, experts from Yangtze River shared their experience in:

• Constructing manufacturing plants in compliance with cGMP (FDA – USA) standards
• Managing quality systems according to international benchmarks
• Long-term cooperation models: product distribution, workforce training partnerships, product design, factory construction, and technology transfer

Both parties committed to sharing resources, strengthening production capacity and quality management systems, with the common goal of conquering the world’s most demanding markets.

Affirming position – Advancing global integration
The signing of this strategic cooperation agreement with Yangtze River marks not only a significant turning point in Nam Ha Pharma’s development journey, but also serves as strong evidence of the credibility and capacity of Vietnam’s pharmaceutical industry on the global stage.

Nam Ha Pharma is committed to upholding its core philosophy of Integrity – Quality – Sustainable Development, and to joining hands with Yangtze River Pharmaceutical Group in expanding its global presence, bringing the best pharmaceutical products to communities worldwide.